Back to search

United States· US:49967-633_b71e6bdf-265f-4314-afee-eae0a683b48d

Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift and Firming Face and Neck All Skin Types

A medicinal product containing avobenzone; octisalate; octocrylene, registered in United States by L'Oreal USA Products Inc.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLancome Paris Renergie Lift MultiActi…ATC—REGISTER NO.US:49967-633_b71e6bdf…PACKS LISTED16CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AVOBENZONE; OCTISALATE; OCTOCRYLENE
Manufacturer
L'Oreal USA Products Inc
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 16

  • ndc11
    4996763301
    1 JAR in 1 CARTON (49967-633-01) / 75 g in 1 JAR
  • ndc11
    4996763302
    1 JAR in 1 CARTON (49967-633-02) / 50 g in 1 JAR
  • ndc11
    4996763303
    1 JAR in 1 CARTON (49967-633-03) / 2 g in 1 JAR
  • ndc11
    4996763304
    200 g in 1 JAR (49967-633-04)
  • ndc11
    4996763305
    2 g in 1 PACKET (49967-633-05)
  • ndc11
    4996763306
    15 g in 1 JAR (49967-633-06)
  • ndc11
    4996763307
    7 g in 1 PACKET (49967-633-07)
  • ndc11
    4996763308
    1 g in 1 PACKET (49967-633-08)
  • ndc11
    49967-633-01
  • ndc11
    49967-633-02
  • ndc11
    49967-633-03
  • ndc11
    49967-633-04
  • ndc11
    49967-633-05
  • ndc11
    49967-633-06
  • ndc11
    49967-633-07
  • ndc11
    49967-633-08

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Avobenzone; octisalate; octocrylene in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All avobenzone; octisalate; octocrylene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8e773dc-91ca-4c8b-b31a-9c3d63a5d9ce
GET /v1/drugs/d8e773dc-91ca-4c8b-b31a-9c3d63a5d9ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "30; 50; 70",
  "substance": "AVOBENZONE; OCTISALATE; OCTOCRYLENE",
  "productndc": "49967-633",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "mg/g; mg/g; mg/g",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about avobenzone; octisalate; octocrylene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.